New plea for MMR vaccination as cases rise

795 cases of mumps and 231 of measles in first quarter of 2019 Related items fromOnMedica Parental confidence in immunisation programme ‘very high’ Results from children ’s flu jab pilots ‘encouraging’ World ’s first malaria vaccine piloted in Malawi babies HPA warns of possible measles epidemic Vaccination of children could target flu best
Source: OnMedica Latest News - Category: UK Health Source Type: news

Related Links:

Thousands of Covid-19 patients have been treated with blood plasma outside of rigorous clinical trials — hampering research that would have shown whether the therapy worked.
Source: NYT Health - Category: Consumer Health News Authors: Tags: your-feed-science Coronavirus (2019-nCoV) Clinical Trials Blood Donation Drugs (Pharmaceuticals) Epidemics Medicine and Health Research Hospitals American Red Cross Brigham and Women ' s Hospital Columbia University Food and Dr Source Type: news
Vaccines protecting against influenza, hepatitis B and rabies are less effective for obese people. As scientists develop a Covid-19 vaccine, experts say obesity could be an impediment, a sobering prospect for the US, where nearly half of all adults are obese.
Source: CNN.com - Health - Category: Consumer Health News Source Type: news
A third US company has released study results showing its coronavirus vaccine is safe and elicits an immune response.
Source: CNN.com - Health - Category: Consumer Health News Source Type: news
In this study, we verified that 1 showed in vivo anti-malarial activity through not only intraperitoneal (i.p.) but also peroral (p.o.) administration. Additionally, some analogs of 1 were synthesized and the structure-activity relationship was analyzed to disclose the crucial sub-structures for the potent activity. PMID: 32741921 [PubMed - in process]
Source: Chemical and Pharmaceutical Bulletin - Category: Drugs & Pharmacology Authors: Tags: Chem Pharm Bull (Tokyo) Source Type: research
Vaccine development normally takes years, if not decades. But scientific teams around the world are aiming to develop a COVID-19 vaccine in 12 to 18 months. Here’s how they’re speeding up the process and why they think a vaccine produced this fast will be just as safe as any other.
Source: CBC | Health - Category: Consumer Health News Tags: News/Health Source Type: news
CONCLUSIONS: Most women did not experience any improvement in their symptoms over time, and no association was found between lack of symptom improvement and believing that the HPV vaccine was causing the symptoms. FUNDING: funded by the Danish Cancer Society. TRIAL REGISTRATION: not relevant. PMID: 32741432 [PubMed - in process]
Source: Danish Medical Journal - Category: General Medicine Tags: Dan Med J Source Type: research
(Wiley) Vaccination against the human papilloma virus (HPV) reduces the risk of a condition that often leads to cervical cancer, according to an analysis of Danish health registry data.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news
Critical media reporting about Operation Warp Speed, the federal government's effort to speed development of drugs, vaccines and other measures to fight the coronavirus pandemic, is distracting people working on the project, its chief adviser says.
Source: CNN.com - Health - Category: Consumer Health News Source Type: news
This report demonstrates the detailed clinico-investigative profile of a child who survived rabies following inadequate post-exposure prophylaxis and adds to the sparse knowledge of this usually fatal condition. ABBREVIATIONS: ADEM, acute disseminated encephalomyelitis; CBNAAT, cartridge-based nucleic acid amplification test; CSF, cerebrospinal fluid; EEG, electroencephalogram; GCS, Glasgow coma scale; EVM, eye opening, best verbal response, best motor response; IM, intramuscular; IVIg, intravenous immunoglobulin; MRC, Medical Research Council; MRI/FLAIR, magnetic resonance imaging/fluid attenuation inversion recovery;...
Source: Paediatrics and international child health - Category: Pediatrics Tags: Paediatr Int Child Health Source Type: research
In early April, about four months after a new, highly infectious coronavirus was first identified in China, an international group of scientists reported encouraging results from a study of an experimental drug for treating the viral disease known as COVID-19. It was a small study, reported in the New England Journal of Medicine, but showed that remdesivir, an unapproved drug that was originally developed to fight Ebola, helped 68% of patients with severe breathing problems due to COVID-19 to improve; 60% of those who relied on a ventilator to breathe and took the drug were able to wean themselves off the machines after 18...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized COVID-19 Source Type: news
More News: Babies | Children | Epidemics | Epidemiology | Malaria | Malaria Vaccine | Malawi Health | Measles | Measles Vaccine | Mumps | Mumps Vaccine | UK Health | Vaccines